pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,970 catalysts · 5,347 phase readout · 2,277 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 18 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,277
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›TERMINATEDphase readoutNCT06136182: Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery

Sponsor: Methodist Health System. Phase: . Conditions: Clinical Outcome of Pericardial Closure Using Gentrix

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07531082: Effects of a Salutogenic Strength-based Social Robot-assisted Intervention on the Depressive Symptoms and Sense of Coherence of Family Caregivers of Persons With Dementia

Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Depressive Sympotoms

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03684980: LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: EARLY_PHASE1. Conditions: Central Nervous System Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT03331380: Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: NA. Conditions: CAD

full page →ctgov ↗
›COMPLETEDphase readoutNCT07417579: Mindfulness and Meditation-Based Relapse Prevention for Substance Use Disorders

Sponsor: Bout Me Healing. Phase: . Conditions: Substance Use Disorders, Behavioral Health, Addiction Psychological, Addiction Disorders, Meditation, Mindfulness Based Stress Reduction, Prevention

full page →ctgov ↗
›COMPLETEDphase readoutNCT05549596: CETIS-I (CEra Traction Improves Spine-I)

Sponsor: Ceragem Clinical Inc.. Phase: NA. Conditions: Lumbar Disc Herniation, Degenerative Spinal Stenosis, Spine Traction

full page →ctgov ↗
›RECRUITINGphase readoutNCT05258396: Exploring Cortical Remyelination in Children With Multiple Sclerosis

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Children With Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05412862: Positive Emotions Following Acute Cardiac Events

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Acute Coronary Syndrome, Physical Inactivity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07005362: Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

Sponsor: University of Colorado, Denver. Phase: . Conditions: Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM), T2DM (Type 2 Diabetes Mellitus), T2D, T2DM, Remote Patient Monitoring, Artificial Intelegence

full page →ctgov ↗
›RECRUITINGphase readoutNCT06474403: Laparoscopic Total Extraperitoneal Plasty as a Modification of Sugabecker's Operation

Sponsor: State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital. Phase: NA. Conditions: Parastomal Hernia

full page →ctgov ↗
›COMPLETEDphase readoutNCT02403661: Electrical Stimulation to Enhance Peripheral Nerve Regeneration

Sponsor: University of Alberta. Phase: NA. Conditions: Peripheral Nerve Injuries

full page →ctgov ↗
›TERMINATEDphase readoutNCT06979570: Personalized Performance Optimization Platform

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Sensory Science, Performance Assessment, Countermeasure Evaluation, Neurocognitive Function, Psychological Factors

full page →ctgov ↗
›COMPLETEDphase readoutNCT06092073: Bilateral Recto-Intercostal Fascial Plane Block in Epigastric Hernia Repair

Sponsor: Tanta University. Phase: NA. Conditions: Recto-intercostal Fascial Plane Block, Epigastric Hernia, Analgesia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07531173: Serotonin Norepinephrine Reuptake Inhibitors and the Risk of Serious Adverse Events

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Phase: . Conditions: Chronic Kidney Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07099469: Compairing R-ICNB and C-ICNB for Postoperative Pain Management After Minimal-invasive Anatomical Lung Resection

Sponsor: University Hospital, Antwerp. Phase: . Conditions: Postoperative Pain Management, RATS Surgery

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06585969: A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer

Sponsor: Danish Breast Cancer Cooperative Group. Phase: PHASE3. Conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, Luminal B, Her2 Enriched, Basal Like

full page →ctgov ↗
›RECRUITINGphase readoutNCT07133269: Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients

Sponsor: Singapore General Hospital. Phase: NA. Conditions: Advanced Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07497269: Conventional vs Pulsed RF in Coccydynia

Sponsor: Adana City Training and Research Hospital. Phase: NA. Conditions: Back Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07624669: A First in Human Study Investigating the Safety of an Unloaded and Loaded (With a Tetanus-containing Vaccine Booster) Microneedle Patch in Healthy Adults

Sponsor: Microneedle Solutions Ltd. Phase: PHASE4. Conditions: Vaccine Delivery, Tetanus

full page →ctgov ↗
›RECRUITINGphase readoutNCT07125469: Comparing Measurements of the Aortic Valve Taken During Surgery With Those Obtained Before Surgery Using Computed Tomography Scans, in Patients Undergoing Surgical Aortic Valve Replacement

Sponsor: Maria Cecilia Hospital. Phase: NA. Conditions: Valvular Heart Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT03650569: Italian Angelman Syndrome Registry

Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS. Phase: . Conditions: Angelman Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT05176483: Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Sponsor: Exelixis. Phase: PHASE1. Conditions: Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor, Hepatocellular Carcinoma (HCC), Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC), Clear Cell Renal Cell Carcinoma (ccRCC), Non-Clear Cell Renal Cell Carcinoma (nccRCC)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07272941: Mindfulness-Based Intervention for Pediatric Mild Traumatic Brain Injury

Sponsor: Children's Hospital of Eastern Ontario. Phase: NA. Conditions: Concussions, Mild Traumatic Brain Injury, Concussion, Concussion Mild

full page →ctgov ↗
›COMPLETEDphase readoutNCT05931835: Feasibility Study on the VERAFEYE System

Sponsor: LUMA Vision Ltd.. Phase: NA. Conditions: Atrial Septal Defect, Atrial Fibrillation, Atrial Arrhythmia, Left Atrial Appendage Closure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07370935: Trunk Stability, Balance, and Fatigue in Minimally to Moderately Disabled People With Multiple Sclerosis

Sponsor: Cappadocia University. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05965635: The Uninfected Ixodes Scapularis Human Tick Challenge Model

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Phase: NA. Conditions: Tick Bites, Immunity to Ticks

full page →ctgov ↗
›RECRUITINGphase readoutNCT07321925: Thermoacoustic Method for Estimating Liver Fat Fraction

Sponsor: Endra Lifesciences. Phase: . Conditions: MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), Fatty Liver Disease, Nonalcoholic

full page →ctgov ↗
›RECRUITINGphase readoutNCT01496625: National Eye Institute Biorepository for Retinal Diseases

Sponsor: National Eye Institute (NEI). Phase: . Conditions: Age-Related Macular Degeneration, Diabetic Retinopathy, Von Hippel-Lindau Syndrome, Retinal Disease, Retinal Vein Occlusion

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07473817: Validation of Different Methods for HepQuant DuO® Blood Sample Collection

Sponsor: HepQuant, LLC. Phase: . Conditions: Healthy Adult Participants, Liver Disease Chronic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07642440: Brief Title Suprapubic Drainage During Transurethral Cystolithotripsy for Large Bladder Stones

Sponsor: Beni-Suef University. Phase: NA. Conditions: Bladder Stone, Cystolithiasis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07409168: Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL

Sponsor: Sun Yat-sen University. Phase: . Conditions: Natural Killer/T-cell Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06249191: Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Sponsor: OHSU Knight Cancer Institute. Phase: PHASE1. Conditions: Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07567274: DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury

Sponsor: Leading Edge Clinic. Phase: PHASE2. Conditions: Tinnitus

full page →ctgov ↗
›TERMINATEDphase readoutNCT05812274: Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

Sponsor: Columbia University. Phase: NA. Conditions: Non Small Cell Lung Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05384990: Sensorimotor Control During Postural Transitions in CP

Sponsor: University of Delaware. Phase: NA. Conditions: Cerebral Palsy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07546097: Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis(UPFRONT)

Sponsor: Yongquan Shi. Phase: PHASE4. Conditions: Acute Severe Ulcerative Colitis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07497997: PainTrain-AI Pilot: Feasibility, Usability (SUS) and Concept-Shift in Primary Care and a Specialized Setting

Sponsor: Francesc Valenzuela Pascual. Phase: NA. Conditions: Chronic Musculoskeletal Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07613710: A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy

Sponsor: H. Lundbeck A/S. Phase: PHASE1. Conditions: Narcolepsy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07552610: Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion

Sponsor: Xuanwu Hospital, Beijing. Phase: NA. Conditions: Acute Ischemic Stroke, Large Vessel Occlusion, Thrombectomy, Neutrophil Extracellular Trap Formation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06101810: The Efficacy of Treatments to Improve Self-esteem

Sponsor: GGZ Noord-Holland-Noord. Phase: NA. Conditions: Self Esteem

full page →ctgov ↗
›RECRUITINGphase readoutNCT06728410: A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

Sponsor: Mehmet Akce. Phase: PHASE2. Conditions: Intrahepatic Cholangiocarcinoma, FGFR2 Gene Rearrangement, FGFR2 Gene Mutation

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07053813: Applying Population Management Best Practices to Preventative Genomic Medicine Trial

Sponsor: University of Washington. Phase: NA. Conditions: Neoplastic Syndromes, Hereditary

full page →ctgov ↗
›COMPLETEDphase readoutNCT07191613: Effects of HAPPY GO GO Game on Health of Rural Elderly

Sponsor: Chang Gung University of Science and Technology. Phase: NA. Conditions: Frailty at Older Adults, Health Promotion

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07392060: A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment

Sponsor: Shanghai Jiatan Pharmatech Co., Ltd. Phase: PHASE3. Conditions: Cervical Cancer Metastatic

full page →ctgov ↗
›COMPLETEDphase readoutNCT02860260: Kinetics of Plasma and Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Patients With Ischemic Stroke

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Ischemic Stroke

full page →ctgov ↗
›COMPLETEDphase readoutNCT07410260: Extracorporeal Shock Wave Therapy for Shoulder Impingement

Sponsor: Istinye University. Phase: NA. Conditions: Extracorporeal Shock Wave Therapy, Shoulder Impingement Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07381660: SBRT Versus Surgical Resection for Small HCC

Sponsor: Sun Yat-sen University. Phase: PHASE3. Conditions: Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05156320: Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam

Sponsor: Scholar Rock, Inc.. Phase: PHASE3. Conditions: Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, SMA, Neuromuscular Diseases, Muscular Atrophy, Atrophy, Muscular Atrophy, Spinal, Neuromuscular Manifestations, Anti-myostatin

full page →ctgov ↗
›RECRUITINGphase readoutNCT07176624: The PRE-VAIL Study

Sponsor: The First Hospital of Jilin University. Phase: NA. Conditions: ARDS (Moderate or Severe), Prone Position, Enteral Nutrition Feeding, Intensive Care Unit (ICU) Admission

full page →ctgov ↗
›COMPLETEDphase readoutNCT05223959: Culturally Adapted Psychoeducation for Bipolar Disorder in a Low-resource Setting: A Randomized Controlled Trial

Sponsor: Pakistan Institute of Living and Learning. Phase: NA. Conditions: Bipolar Disorder

full page →ctgov ↗
← prev
page 109 of 160
next →